publication venue for
- IXEKIZUMAB IMPROVES PATIENT-REPORTED OUTCOMES THROUGH 52 WEEKS IN PATIENTS WITH ACTIVE PSORIATIC ARTHRITIS AND PREVIOUS INADEQUATE RESPONSE TO TUMOR NECROSIS FACTOR-INHIBITORS 2018
- P57: REVIEW OF EVIDENCE AND GAPS IN KNOWLEDGE ON THUNDERSTORM ASTHMA EPIDEMICS AND PUBLIC HEALTH IMPLICATIONS 2017
- REVIEW OF NUCLEAR CARDIOLOGY PRACTICES AND RADIATION EXPOSURE IN THE OCEANIA REGION: RESULTS FROM THE IAEA NUCLEAR CARDIOLOGY PROTOCOLS STUDY (INCAPS) 2015
- The Australian Team Approach to Polypharmacy Evaluation and Reduction (AusTAPER) hospital study: effect of a collaborative medication review on the number of current regular medicines for older hospital inpatients.. 54:1719-1732. 2024
- Multi‐centre ethics and research governance review can impede non‐interventional clinical research. 49:722-728. 2019
- Early and late changes in markers of aortic stiffness with breast cancer therapy. 45:140-147. 2015
-
Trends in the use of implantable cardioverter defibrillators in
A ustralia: a 10‐year nationwide study from 2000–2009. 43:888-895. 2013 -
How do we manage venous thromboembolism in pregnancy? A retrospective review of the practice of diagnosing and managing pregnancy‐related venous thromboembolism at two major hospitals in
A ustralia andN ewZ ealand. 42:1104-1112. 2012 - Barriers faced by migrants in accessing healthcare for viral hepatitis infection. 42:491-496. 2012
- General practitioners' knowledge and management of viral hepatitis in the migrant population. 42:497-504. 2012
- Determinants of masked hypertension in hypertensive patients treated in a primary care setting. 42:260-266. 2012
- Reply. 41:583-583. 2011
- What is the role of invasive versus non‐invasive coronary angiography in the investigation of patients suspected to have coronary heart disease?. 41:5-13. 2011
- Evidence‐based management of heart failure in clinical practice: a review of device‐based therapy use. 39:669-675. 2009
- Methylene tetrahydrofolate reductase mutation and stroke in a monozygotic twin. 28:849-850. 1998
- Evidence of no difference or just no evidence of any difference. 27:600-600. 1997
- Hepatitis C genotypes in Australian haemophilia patients. 26:789-792. 1996
- Does activated protein C resistance increase the risk of systemic embolism in non rheumatic atrial fibrillation?. 26:243-244. 1996
- Tamoxifen flare — an unusual case of hypercalcaemia and transient rapidly progressive pancytopenia. 25:375-376. 1995
- Sheepskins and bedding in childhood, and the risk of development of bronchial asthma. 24:687-692. 1994
- Overview of low molecular weight heparins and heparinoids: basic and clinical aspects.. 22:487-495. 1992
- THE DRUG TREATMENT OF DUODENAL ULCER: PHYSIOLOGICAL CONSIDERATIONS IN THE CHOICE OF THERAPY. 16:263-267. 1986
- LIDOCAINE AND THE REDUCTION OF POST‐VENOGRAPHIC PAIN. 14:622-625. 1984
- The Activated Partial Thromboplastin Time in the Control of Heparin Treatment. 19:334-337. 1970
- Dosage Regimens for Streptokinase Treatment: Evaluation of a Standard Dosage Schedule. 19:12-16. 1970
- Streptokinase in the Treatment of Major Pulmonary Embolism—Experience with Twenty‐five Patients. 19:54-59. 1970